About NDV-01 NDV-01 is an investigational, innovative sustained-release formulation of two complementary, well-established, chemotherapy agents, gemcitabine and docetaxel (gem/doce). It is designed ...

Lead investigational program, NDV-01, for High-Grade Non-Muscle Invasive Bladder Cancer, is being evaluated in a Phase 2 study. In addition, preparations are underway to advance sepranolone, a Phase ...

Amid the economic unease triggered by tariff uncertainties, Paris’ spring sales offered a glimmer of confidence ahead of New ...

Microsoft has released the KB5055617 build to the Dev Channel for Windows Insiders using Windows 11, version 24H2. It brings ...

The U.S. government has an official plan for a zombie apocalypse Think The Walking Dead is straight-up fiction? Well, it ...